News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Jenrin Discovery Announces Recent Advances in Understanding of the Endocannabinoid System Using JD-5037


9/12/2013 9:31:26 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

PHILADELPHIA, Sept. 11, 2013 (GLOBE NEWSWIRE) -- Research published in Nature Medicine and Journal of Hepatology by scientists at the National Institutes of Health using JD-5037, the best-in-class peripheral CB1 inverse agonist from Jenrin Discovery, LLC has illuminated the mechanism of action for this class of drugs, providing a rationale for the potential therapeutic benefits seen when only peripheral endocannabinoid receptors are inhibited.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES